{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T22:59:44Z","timestamp":1789685984044,"version":"4.0.1"},"reference-count":26,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archives of Cardiovascular Diseases"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.acvd.2025.11.012","type":"journal-article","created":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T07:43:24Z","timestamp":1769672604000},"page":"302-308","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Direct oral anticoagulants versus vitamin K antagonists after heart valve bioprosthetic replacement or repair: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"119","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8193-9559","authenticated-orcid":false,"given":"Vito D.","family":"Bruno","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"Lester","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrico","family":"Poletti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5586-619X","authenticated-orcid":false,"given":"Bleri","family":"Celmeta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2052-4891","authenticated-orcid":false,"given":"Tommaso","family":"Viva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arturo","family":"Bisogno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Miceli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mattia","family":"Glauber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.acvd.2025.11.012_bib0135","first-page":"E72","article-title":"2020 ACC\/AHA Guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"143","author":"Otto","year":"2021","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.acvd.2025.11.012_bib0140","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1093\/eurheartj\/ehab395","article-title":"2021 ESC\/EACTS Guidelines for the management of valvular heart disease","volume":"43","author":"Vahanian","year":"2022","journal-title":"Eur Heart J"},{"issue":"22","key":"10.1016\/j.acvd.2025.11.012_bib0145","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1056\/NEJMoa2029603","article-title":"Rivaroxaban in patients with atrial fibrillation and a bioprosthetic mitral valve","volume":"383","author":"Guimar\u00e3es","year":"2020","journal-title":"N Engl J Med"},{"issue":"13","key":"10.1016\/j.acvd.2025.11.012_bib0150","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.017559","article-title":"Direct oral anticoagulant use: a practical guide to common clinical challenges","volume":"9","author":"Chen","year":"2020","journal-title":"J Am Heart Assoc"},{"issue":"12","key":"10.1016\/j.acvd.2025.11.012_bib0155","doi-asserted-by":"crossref","first-page":"4797","DOI":"10.19102\/icrm.2021.121202","article-title":"Direct oral anticoagulants in patients with atrial fibrillation and bioprosthetic valves\u00a0\u2013\u00a0a systematic review and meta-analysis","volume":"12","author":"Ruzieh","year":"2021","journal-title":"J Innovations Cardiac Rhythm Manag"},{"key":"10.1016\/j.acvd.2025.11.012_bib0160","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.thromres.2022.01.023","article-title":"Potentially inappropriate prescribing of DOACs to people with mechanical heart valves: a federated analysis of 57.9 million patients\u2019 primary care records in situ using OpenSAFELY","volume":"211","author":"Fisher","year":"2022","journal-title":"Thromb Res"},{"key":"10.1016\/j.acvd.2025.11.012_bib0165","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.acvd.2025.11.012_bib0170","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13643-016-0384-4","article-title":"Rayyan\u00a0\u2013\u00a0a web and mobile app for systematic reviews","volume":"5","author":"Ouzzani","year":"2016","journal-title":"Syst Rev"},{"key":"10.1016\/j.acvd.2025.11.012_bib0175","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/j.acvd.2025.11.012_bib0180","unstructured":"Wells G, Shea B, O\u2019Connell D, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. https:\/\/ohri.ca\/en\/who-we-are\/core-facilities-and-platforms\/ottawa-methods-centre\/newcastle-ottawa-scale"},{"issue":"12","key":"10.1016\/j.acvd.2025.11.012_bib0185","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1016\/j.jacc.2007.10.058","article-title":"Thromboembolic complications after surgical correction of mitral regurgitation. Incidence, predictors, and clinical implications","volume":"51","author":"Russo","year":"2008","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"10.1016\/j.acvd.2025.11.012_bib0190","doi-asserted-by":"crossref","first-page":"2520","DOI":"10.1177\/0962280219889080","article-title":"Estimating the sample mean and standard deviation from commonly reported quantiles in meta-analysis","volume":"29","author":"McGrath","year":"2020","journal-title":"Stat Methods Med Res"},{"key":"10.1016\/j.acvd.2025.11.012_bib0195","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1745-6215-8-16","article-title":"Practical methods for incorporating summary time-to-event data into meta-analysis","volume":"8","author":"Tierney","year":"2007","journal-title":"Trials"},{"issue":"9","key":"10.1016\/j.acvd.2025.11.012_bib0200","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1007\/s40261-020-00939-x","article-title":"Comparison of the efficacy and safety of direct oral anticoagulants and warfarin after bioprosthetic valve replacements","volume":"40","author":"Pasciolla","year":"2020","journal-title":"Clin Drug Investig"},{"issue":"1","key":"10.1016\/j.acvd.2025.11.012_bib0205","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.jtcvs.2021.01.127","article-title":"Efficacy and safety of edoxaban in patients early after surgical bioprosthetic valve implantation or valve repair: a randomized clinical trial","volume":"165","author":"Shim","year":"2023","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.acvd.2025.11.012_bib0210","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1016\/j.jtcvs.2019.09.064","article-title":"Non-vitamin K oral anticoagulant use after cardiac surgery is rapidly increasing","volume":"160","author":"Beller","year":"2020","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"3","key":"10.1016\/j.acvd.2025.11.012_bib0215","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1007\/s11239-020-02046-2","article-title":"Rivaroxaban in patients undergoing surgical mitral valve repair","volume":"49","author":"Noohi","year":"2020","journal-title":"J Thromb Thrombolysis"},{"issue":"4","key":"10.1016\/j.acvd.2025.11.012_bib0220","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1016\/j.athoracsur.2022.07.045","article-title":"Apixaban for anticoagulation after robotic mitral valve repair","volume":"115","author":"Mazur","year":"2023","journal-title":"Ann Thorac Surg"},{"issue":"1","key":"10.1016\/j.acvd.2025.11.012_bib0225","doi-asserted-by":"crossref","first-page":"46","DOI":"10.14423\/SMJ.0000000000001193","article-title":"Efficacy and safety of nonvitamin K oral anticoagulants following cardiac valve replacement","volume":"114","author":"Stuart","year":"2021","journal-title":"South Med J"},{"key":"10.1016\/j.acvd.2025.11.012_bib0230","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1016\/j.athoracsur.2023.05.025","article-title":"Long-term outcomes and anticoagulation in mitral valve surgery\u2014A report from the Society of Thoracic Surgeons Database","volume":"116","author":"Schwann","year":"2023","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.acvd.2025.11.012_bib0235","article-title":"Anticoagulation therapy for non-valvular atrial fibrillation: a mini-review","volume":"7","author":"Wu","year":"2020","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.acvd.2025.11.012_bib0240","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1056\/NEJMoa1300615","article-title":"Dabigatran versus Warfarin in patients with mechanical heart valves","volume":"369","author":"Eikelboom","year":"2013","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.acvd.2025.11.012_bib0245","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.acvd.2024.10.324","article-title":"Epidemiology of valvular heart disease in France","volume":"117","author":"Grave","year":"2024","journal-title":"Arch Cardiovasc Dis"},{"issue":"4","key":"10.1016\/j.acvd.2025.11.012_bib0250","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.clinthera.2023.03.008","article-title":"Mortality on DOACs versus on vitamin K antagonists in atrial fibrillation: analysis of the Hungarian Health Insurance Fund Database","volume":"45","author":"Papp","year":"2023","journal-title":"Clin Ther"},{"issue":"5","key":"10.1016\/j.acvd.2025.11.012_bib0255","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1111\/jgs.12799","article-title":"New oral anticoagulants in elderly adults: evidence from a meta-analysis of randomized trials","volume":"62","author":"Sardar","year":"2014","journal-title":"J Am Geriatr Soc"},{"issue":"4","key":"10.1016\/j.acvd.2025.11.012_bib0260","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1177\/1556984520934632","article-title":"Massive left atrial thrombus after a left atrial surgical ablation and bioprosthetic mitral valve replacement","volume":"15","author":"Maniar","year":"2020","journal-title":"Innovations (Phila)"}],"container-title":["Archives of Cardiovascular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1875213626000082?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1875213626000082?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T17:39:22Z","timestamp":1775756362000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1875213626000082"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":26,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S1875213626000082"],"URL":"https:\/\/doi.org\/10.1016\/j.acvd.2025.11.012","relation":{},"ISSN":["1875-2136"],"issn-type":[{"value":"1875-2136","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Direct oral anticoagulants versus vitamin K antagonists after heart valve bioprosthetic replacement or repair: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Archives of Cardiovascular Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.acvd.2025.11.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}